November 8, 2011: Health Canada Endorsed Important Safety Information on Pradax and Plavix
Boehringer Ingelheim (Canada) Ltd. and Sanofi-aventis Canada Inc., in consultation with Health Canada, are alerting consumers and healthcare professionals to the risk of medication errors associated with name confusion between the anticoagulant Pradax (dabigatran etexilate) and the antiplatelet drug Plavix (clopidogrel bisulfate).More information is available on the Health Canada website:
For the Public
